SA
DMRA

S&P 500, Nasdaq, Russell 2000 below the 200-day average · VIX 35.9 · very high volatility

Overview →

Damora Therapeutics, Inc. (DMRA)

Total Liabilities

$36.87M

Quarterly · Period ending: · USD

DMRA logo

DMRA Total Liabilities

Latest reported$20.15M
DMRA FY Total Liabilities ($4.44M → $20.15M)
High-resolution chart · PNG

What is total liabilities?

Total amount the company owes to creditors.

DMRA total liabilities history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years. Change compares each value with the period before it.

Damora Therapeutics, Inc. Total Liabilities — Annual fiscal periods (USD)
Period endingTotal Liabilities (USD)Change
20,147,000+657.12%
2,661,000−54.87%
5,896,000−48.44%
11,435,000+129.07%
4,992,000−18.26%
6,107,000−24.96%
8,138,000+83.12%
4,444,000—

Frequently asked questions: DMRA total liabilities

What is Damora Therapeutics, Inc. (DMRA)'s current total liabilities?

Damora Therapeutics, Inc. (DMRA)'s latest reported total liabilities (Quarterly) is $36.87M as of Sep 30, 2026. Total amount the company owes to creditors.

How much historical total liabilities data is available for DMRA?

Stock Alarm Pro provides 8 dated annual fiscal periods observations for Damora Therapeutics, Inc. (DMRA)'s total liabilities, allowing investors to analyze multi-year trends and cycle inflection points in Chart Studio.

How can I compare DMRA's total liabilities to peers or set an alert?

You can open DMRA's total liabilities in Stock Alarm Pro Chart Studio to overlay price and valuation multiples, or set real-time alerts on DMRA delivered by push, email, or phone call.

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.